Official 2023 U.S. DOL Form 5500 summary for Oyster Point Pharma, INC. (Oyster Point Pharma, INC. 401(k) Plan · EIN 81-1030955 · PN 001): $16.93M net assets, 240 active participants, and $79.80 per $10,000 (79.80 bps).
| Plan Sponsor | Oyster Point Pharma, INC. |
|---|---|
| Filing Identifier | Oyster Point Pharma, INC. 401(k) Plan · EIN 81-1030955 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2023) | $16.93M |
| Active Participants | 240 |
| Direct Admin Fee Rate | $79.80 per $10,000 (79.80 bps) |
| Cohort Peer Median | $34.74 per $10,000 (34.74 bps) |
| Primary Recordkeeper / Provider | T. Rowe Price |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI